Medical device giant Medtronic has brought a major breakthrough for the 1.25 million type 1 diabetics as it previously announced on September 28 that the US Food and Drug Administration (FDA) has approved of the medical powerhouse’s MiniMed 670G—a device that acts as artificial pancreas for type 1 diabetes patients.

The approval of the said device was done six months early than scheduled. MiniMed 670G is the world’s first closed loop system to be permitted by a regulatory agency— and this is no minor feat considering European regulators often beat US-based ones for approvals.